☰

Richard Allen - Publications

Affiliations: 
University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Tree Info Grants Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Mandt BH, Larson C, Fay T, Bludeau P, Allen RM, Deitrich RA, Radcliffe RA. Quantitative trait loci for sensitivity to acute ethanol and ethanol consummatory behaviors in rats. Alcohol (Fayetteville, N.Y.). 66: 55-67. PMID 29182922 DOI: 10.1016/J.Alcohol.2017.08.002  0.747
2015 Mandt BH, Copenhagen LI, Zahniser NR, Allen RM. Escalation of cocaine consumption in short and long access self-administration procedures. Drug and Alcohol Dependence. 149: 166-72. PMID 25697912 DOI: 10.1016/J.Drugalcdep.2015.01.039  0.803
2015 Allen RM, Mandt BH, Jaskunas J, Hackley A, Shickedanz A, Bergkamp D. Continuous exposure to dizocilpine facilitates the acquisition and escalation of cocaine consumption in male Sprague-Dawley rats. Drug and Alcohol Dependence. 147: 137-43. PMID 25523326 DOI: 10.1016/J.Drugalcdep.2014.11.027  0.842
2014 Allen RM. Continuous exposure to dizocilpine facilitates escalation of cocaine consumption in male Sprague-Dawley rats. Drug and Alcohol Dependence. 134: 38-43. PMID 24103127 DOI: 10.1016/j.drugalcdep.2013.09.005  0.575
2013 Simmons DL, Mandt BH, Ng CM, Richards TL, Yamamoto DJ, Zahniser NR, Allen RM. Low- and high-cocaine locomotor responding rats differ in reinstatement of cocaine seeking and striatal mGluR5 protein expression. Neuropharmacology. 75: 347-55. PMID 23973314 DOI: 10.1016/J.Neuropharm.2013.08.001  0.83
2013 Yamamoto DJ, Nelson AM, Mandt BH, Larson GA, Rorabaugh JM, Ng CM, Barcomb KM, Richards TL, Allen RM, Zahniser NR. Rats classified as low or high cocaine locomotor responders: a unique model involving striatal dopamine transporters that predicts cocaine addiction-like behaviors. Neuroscience and Biobehavioral Reviews. 37: 1738-53. PMID 23850581 DOI: 10.1016/J.Neubiorev.2013.07.002  0.827
2012 Mandt BH, Gomez E, Johnston NL, Zahniser NR, Allen RM. Cocaine dose and self-administration history, but not initial cocaine locomotor responsiveness, affects sensitization to the motivational effects of cocaine in rats. The Journal of Pharmacology and Experimental Therapeutics. 342: 214-21. PMID 22518023 DOI: 10.1124/Jpet.112.194092  0.832
2012 Mandt BH, Johnston NL, Zahniser NR, Allen RM. Acquisition of cocaine self-administration in male Sprague-Dawley rats: effects of cocaine dose but not initial locomotor response to cocaine. Psychopharmacology. 219: 1089-97. PMID 21863236 DOI: 10.1007/S00213-011-2438-6  0.831
2009 Mandt BH, Allen RM, Zahniser NR. Individual differences in initial low-dose cocaine-induced locomotor activity and locomotor sensitization in adult outbred female Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior. 91: 511-6. PMID 18817807 DOI: 10.1016/J.Pbb.2008.09.002  0.825
2008 Mandt BH, Schenk S, Zahniser NR, Allen RM. Individual differences in cocaine-induced locomotor activity in male Sprague-Dawley rats and their acquisition of and motivation to self-administer cocaine. Psychopharmacology. 201: 195-202. PMID 18685831 DOI: 10.1007/S00213-008-1265-X  0.833
2007 Allen RM, Uban KA, Atwood EM, Albeck DS, Yamamoto DJ. Continuous intracerebroventricular infusion of the competitive NMDA receptor antagonist, LY235959, facilitates escalation of cocaine self-administration and increases break point for cocaine in Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior. 88: 82-8. PMID 17716714 DOI: 10.1016/J.Pbb.2007.07.009  0.818
2007 Allen RM, Everett CV, Nelson AM, Gulley JM, Zahniser NR. Low and high locomotor responsiveness to cocaine predicts intravenous cocaine conditioned place preference in male Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior. 86: 37-44. PMID 17250883 DOI: 10.1016/J.Pbb.2006.12.005  0.752
2007 Allen RM, Dykstra LA, Carelli RM. Continuous exposure to the competitive N-methyl-D: -aspartate receptor antagonist, LY235959, facilitates escalation of cocaine consumption in Sprague-Dawley rats. Psychopharmacology. 191: 341-51. PMID 17225167 DOI: 10.1007/s00213-006-0661-3  0.795
2005 Allen RM, Carelli RM, Dykstra LA, Suchey TL, Everett CV. Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement. The Journal of Pharmacology and Experimental Therapeutics. 315: 449-57. PMID 16024734 DOI: 10.1124/jpet.105.086355  0.8
2004 Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS. Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. European Journal of Pharmacology. 501: 111-9. PMID 15464069 DOI: 10.1016/j.ejphar.2004.08.028  0.515
2003 Allen RM, Granger AL, Dykstra LA. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor. The Journal of Pharmacology and Experimental Therapeutics. 307: 785-92. PMID 12975489 DOI: 10.1124/jpet.103.055319  0.527
2002 Dykstra LA, Granger AL, Allen RM, Zhang X, Rice KC. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure. Psychopharmacology. 163: 420-9. PMID 12373443 DOI: 10.1007/s00213-002-1100-8  0.525
2002 Allen RM, Granger AL, Dykstra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 300: 435-41. PMID 11805202 DOI: 10.1124/jpet.300.2.435  0.519
2001 Allen RM, Dykstra LA. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 298: 288-97. PMID 11408554  0.527
2000 Allen RM, Dykstra LA. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude. The Journal of Pharmacology and Experimental Therapeutics. 295: 1012-21. PMID 11082436  0.517
2000 Allen RM, Dykstra LA. Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist. Psychopharmacology. 148: 59-65. PMID 10663418 DOI: 10.1007/S002130050025  0.538
1999 Allen RM, Dykstra LA. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats. Psychopharmacology. 142: 209-14. PMID 10102774 DOI: 10.1007/s002130050881  0.54
1998 Pitts RC, Allen RM, Walker EA, Dykstra LA. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys. The Journal of Pharmacology and Experimental Therapeutics. 285: 1197-206. PMID 9618423  0.524
Show low-probability matches.